About Us

Psyneurgy Pharmaceuticals is developing new treatments for psychiatric and neurological disorders. Our current focus is developing an oral treatment to improve restrictive and repetitive behaviors for autism spectrum disorder patients.

Our team has over 30 years of experience in drug development research and working with the pharmaceutical industry. As we continue our promising research, we’re actively pursuing investors and pharmaceutical partners in anticipation of a Phase II clinical trials.

Our Team

William Messer

William S. Messer, Jr., Ph.D.
President and Chief Scientific Officer

Austin Horton

Austin Horton
Lead Scientist

The owner of this website has made a commitment to accessibility and inclusion, please report any problems that you encounter using the contact form on this website. This site uses the WP ADA Compliance Check plugin to enhance accessibility.